CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2

Infection and Immunity

Volumn 73, Issue 9, 2005, Pages 6017-6025

  Araújo, Adriano F S ^a   De Alencar, Bruna C G ^a   Vasconcelos, Josée Ronnie C ^a   Hiyane, Meire I ^a   Marinho, Cláudio R F ^b   Penido, Marcus L O ^c   Boscardin, Silvia B ^a   Hoft, Daniel F ^d   Gazzinelli, Ricardo T ^c   Rodrigues, Mauricio M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALHYDROGEL 85 SUPERFOS; ALUMINUM POTASSIUM SULFATE; CD8 ANTIGEN; DNA VACCINE; GLUTATHIONE TRANSFERASE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYNUCLEOTIDE; PLASMID DNA; RECOMBINANT AMASTIGOTE SURFACE PROTEIN 2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IN VIVO STUDY; INFECTION CONTROL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; DISEASE SUSCEPTIBILITY; FEMALE; MICE; MICE, INBRED A; NEURAMINIDASE; PROTOZOAN VACCINES; TRYPANOSOMA CRUZI; VACCINES, SYNTHETIC;

EID: 23944437463     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.9.6017-6025.2005     Document Type: Article

References (34)

1. Ackerman, A. L., and P. Cresswell. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5:678-684.
2. Boscardin, S. B., S. S. Kinoshita, A. E. Fujimura. and M. M. Rodrigues. 2003. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect. Immun. 71:2744-2757.
3. Costa, F., G. Franchin, V. L. Pereira-Chioccola, M. Ribeirão, S. Schenkman, and M. M. Rodrigues. 1998. Immunization with a plasmid DNA containing the gene of trams-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16:768-774.
4. Dumonteil, E., J. Escobedo-Ortegon, N. Reyes-Rodriguez, A. Arjona-Torres, and M. J. Ramirez-Sierra. 2004. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice. Infect. Immun. 72:46-53.
5. Fralish, B. H., and R. L. Tarleton. 2003. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine 21:3070-3080.
6. Frank, F. M., P. B. Petray, S. I. Cazorla, M. C. Munoz, R. S. Corral, and E. L. Malchiodi. 2003. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes. Vaccine 22:77-86.
7. + T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect. Immun. 69:5477-5486.
8. Garg, N., and R. Tarleton. 2002. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 70:5547-5555.
9. Heath, W. R., G. T. Belz, G. M. Behrens, C. M. Smith, S. P. Forehan, I. A. Parish, G. M. Davey, N. S. Wilson, F. R. Carbone, and J. A. Villadangos. 2004. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199:9-26.
10. Heit, A., K. M. Huster, F. Schmitz, M. Schiemann, D. H. Busch, and H. Wagner. 2004. CpG-DNA aided cross-priming by cross-presenting B cells. J. Immunol. 172:1501-1507.
11. Heit, A., T. Maurer, H. Hochrein, S. Bauer, K. M. Huster, D. H. Busch, and H. Wagner. 2003. Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells. J. Immunol. 170:2802-2805.
12. Katae, M., Y. Miyahira, K. Takeda, H. Matsuda, H. Yagita, K. Okumura, T. Takeuchi, T. Kamiyama, A. Ohwada, Y. Fukuchi, and T. Aoki. 2002. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy. Infect. Immun. 70:4833-4840.
13. Krettli, A. L., and Z. Brener. 1976. Protective effects of specific antibodies in Trypanosoma cruzi infections. J. Immunol. 116:755-760.
14. Letvin, N. L., D. C. Montefiori, Y. Yasutomi, H. C. Perry, M. E. Davies, C. Lekutis, M. Alroy, D. C. Freed, C. I. Lord, L. K. Handt, M. A. Liu, and J. W. Shiver. 1997. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA 94:9378-9383.
15. Li, S., M. Rodrígues, D. Rodriguez, J. R. Rodriguez, M. Esteban, P. Palese, R. S. Nussenzweig, and F. Zavala. 1993. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA 90:5214-5218.
16. Luhrs, K. A., D. L. Fouts, and J. E. Manning. 2003. Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection. Vaccine 21:3058-3069.
17. Martin, D., and R. Tarleton. 2004. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol. Rev. 201:304-317.
18. Morel, C. M., and J. Lazdins. 2003. Chagas disease. Nat. Rev. Microbiol. 1:14-15.
19. Nyika, A., A. F. Barbet, M. J. Burridge, and S. M. Mahan. 2002. DNA vaccination with map1 gene followed by protein boost augments protection against challenge with Cowdria ruminantium, the agent of heartwater. Vaccine 20:1215-1225.
20. Ouaissi, A., E. Guilvard, Y. Delneste, G. Caron, G. Magistrelli, N. Herbault, N. Thieblemont, and P. Jeannin. 2002. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J. Immunol. 168:6366-6374.
21. Planelles, L., M. C. Thomas, C. Alonso, and M. C. Lapez. 2001. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect. Immun. 69:6558-15563.
22. Rodrigues, M. M., S. B. Boscardin, J. R. Vasconcelos, M. I. Hiyane, G. Salay, and I. S. Soares. 2003. Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines. An. Acad. Bras. Cienc. 75:443-468.
23. Schnapp, A. R., C. S. Eickhoff, D. Sizemore, R. Curtiss III, and D. F. Hoft. 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect. Immun. 70:5065-5074.
24. Sepulveda, P., M. Hontebeyrie, P. Liegeard, A. Mascilli, and K. A. Norris. 2000. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection. Infect. Immun. 68:4986-4991.
25. Silva, L. H. P., and V. Nussenzweig. 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin. Biol. 20:191-203.
26. Song, M. K., S. W. Lee, Y. S. Suh, K. J. Lee, and Y. C. Sung. 2000. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice. J. Virol. 74:2920-2925.
27. Tangbe, A., S. D'Souza, V. Rosseels, O, Denis, T. H. Ottenhoff, W. Dalemans, C. Wheeler, and K. Huygen. 2001. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect. Immun. 69:3041-3047.
28. Vasconcelos, J. R., M. I. Hiyane, C. R. F. Marinho, C. Claser, A. M. Vieira-Machado, R. T. Gazinelli, O. Bruña-Romero, J. M. Alvarez, S. B. Boscardin, and M. M. Rodrigues. 2004. Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain following vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Hum. Gene Ther. 15:878-886.
29. Vasconcelos, J. R., S. B. Boscardin, M. I. Hiyane, S. S. Kinoshita, A. E. Fujimura, and M. M. Rodrigues. 2003. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain. Immunol. Cell Biol. 81:121-129.
30. Wagner, H., A. Heit, F. Schmitz, and S. Bauer. 2004. Targeting split vaccines to the endosome improves vaccination. Curr. Opin. Biotechnol. 15:538-542.
31. Wizel, B., N. Garg, and R. Tarleton. 1998. Vaccination with trypomastigotes surface antigen1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:5073-5081.
32. Wrightsman, R. A., B. D. Dawson, D. L. Fouts, and J. E. Manning. 1994. Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes. J. Immunol. 153:3148-3154.
33. Wrightsman, R. A., and J. E. Manning. 2000. Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi. Vaccine 18:1419-1427.
34. + cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells. Parasite Immunol. 24:401-412.